Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10253110 Anti-FAP antibodies and methods of use

Patent 10253110 was granted and assigned to Roche on April, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Roche

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10253110

Date of Patent

April 9, 2019

Patent Application Number

14661839

Date Filed

March 18, 2015

Patent Citations Received

‌

US Patent 11447558 Bispecific antigen binding molecules comprising anti-4-1BB clone 20H4.9

‌

US Patent 11608376 Tumor-targeted agonistic CD28 antigen binding molecules

‌

US Patent 11639394 Bispecific antigen binding molecule for a costimulatory TNF receptor

‌

US Patent 11780919 Bispecific antigen binding molecules targeting OX40 and FAP

‌

US Patent 11242396 Bispecific antigen binding molecules comprising anti-FAP clone 212

Patent Primary Examiner

‌

Laura B Goddard

Patent abstract

The invention provides antibodies against Fibroblast Activation Protein (FAP) and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10253110 Anti-FAP antibodies and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API